Header links
Intranet
Dona
image/svg+xml Mapa
Contacte

Phase 3 Randomized, Double-blind, Placebo controlled Study to Evaluatethe Efficacy and Safety of Maridebart Cafraglutide on Mort

Phase 3 Randomized, Double-blind, Placebo controlled Study to Evaluatethe Efficacy and Safety of Maridebart Cafraglutide on Mortality and Morbidity inParticipants Living With Heart Failure With Preserved or Mildly Reduced Ejection Fractionand Obesity (MARITIME-HF)]

Obert
  • Codi protocol: 20230227
  • Codi EudraCT: No aplica
  • Grup de recerca: Malalties Cardiovasculars
  • Servei: Cardiologia
  • Investigador/a principal:  Soriano Colomé, Toni
  • Malaltia: Malalties del sistema circulatori
  • Fase: Fase III